Our motivation to specifically investigate the impact of rs143348853 on CLL disease susceptibility and/or progression was driven by its unique impact on AXIN2 expression in CLL cells and the latter gene’s property as a tumor-suppressor34. This evidence concerns the gene AXIN2 and neoplasm.